The new facility was launched at the PharmNXT Biotech LLP, the company’s facility in Chakan, Pune, in the presence of eminent leaders from the Indian biopharma fraternity. The event began with the keynote address by Dr Dhananjay Patankar, thought leader in the BioPharma industry on the aspect of single use technologies within biopharma space and how manufacturing these technologies in India is very crucial to address the supply dependencies on foreign suppliers.
Single-use bioprocessing has recently experienced tremendous growth in biopharmaceutical manufacturing market share. It has also enjoyed technological advances ranging from material properties to implementation of Industry 4.0. It is a relatively new concept in the production of biopharmaceuticals, but is cost-effective, requires low maintenance and leads to low operational expenditures.
Housing the latest production technology, the company plans to cater to the demands from global markets such as Singapore, Korea, Europe and the US. The new facility will also generate employment opportunities to over 100 to 200 people. The ekuse manufacturing facility will be engaged in crafting the Xelta range of single-use bioprocessing products and ‘NXTmix’ a levitating mixing technology.
“With the launch of this unit, we have stepped up our efforts to empower our regional & global clients and provide single-use products, solutions at an accelerated pace. It is our vision to understand customer needs and provide solutions that bring efficiency & consistency in their manufacturing. We are going to manufacture single use technologies like single use storage bags and single use mixing solutions from this site,” said Sachin Joshi, Founder, PharmNXT Biotech in a statement.